This inventor holds 2 USPTO granted patents. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: Beth Fernandez: Innovator in Nrf2 Activating Compounds
Introduction
Beth Fernandez is a prominent inventor based in Pacifica, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs that activate Nrf2. With a total of 2 patents, her work focuses on addressing autoimmune and inflammatory diseases.
Latest Patents
Fernandez's latest patents include innovative prodrugs of Nrf2 activating compounds. These prodrugs are designed for the treatment of various autoimmune and inflammatory diseases, such as psoriasis and multiple sclerosis. The patents detail pharmaceutical compositions that incorporate these prodrugs, methods for their application in treating diseases, and processes for their preparation, including intermediates useful in these processes.
Career Highlights
Beth Fernandez is currently associated with Rigel Pharmaceuticals, Incorporated, where she continues to advance her research and development efforts. Her work is pivotal in creating therapeutic solutions that can significantly improve patient outcomes in the realm of autoimmune disorders.
Collaborations
Some of her notable coworkers include Jiaxin Yu and Gary Park, who collaborate with her on various projects within the pharmaceutical sector.
Conclusion
Beth Fernandez stands out as an influential inventor in the pharmaceutical industry, particularly for her innovative work on Nrf2 activating compounds. Her contributions are vital in the ongoing fight against autoimmune and inflammatory diseases.